|
2-40.005 |
Rescheduling Specified Drug Products Containing Hydrocodone as Schedule III Substances (Repealed) |
1/2/2008 |
|
2-40.006 |
Addition of Alphamethyltryptamine (AMT) to Schedule I, Subsection 893.03(1), F.S (Repealed) |
2/2/2012 |
|
2-40.007 |
Rescheduling of a Drug Product in Finished Dosage Formulation That Has Been Approved by the U.S. Food and Drug Administration That Contains Cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) Derived from Cannabis and No More Than 0.1 Percent (w/w) Residual Tetrahydrocannabinols |
2/7/2019 |
|